Literature DB >> 10211308

Pretreatment assessment and dental management of patients with nasopharyngeal carcinoma.

J B Epstein1, S Emerton, R Lunn, N Le, F L Wong.   

Abstract

Patients who present with nasopharyngeal carcinoma (NPC) require through oral and dental assessment prior to treatment of the malignancy. We assessed the oral status of 57 consecutive patients with a diagnosis of NPC. In this study, identified risk factors for NPC were seen to be different in Asian versus non-Asian patients. Epstein-Barr virus seropositivity was seen in all Asian patients and in 69% of non-Asian patients (P = 0.00006), and reported alcohol use was greater in the non-Asian patients. In this study it was found that 68% of dentate patients required dental extractions primarily due to periodontal disease. Even in patients who reported receiving regular dental care (28%) extractions prior to radiation therapy were suggested. Oral complications of radiation therapy were reported by 84% of patients, with the most common being xerostomia. Clinical diagnosis of candidiasis (16%), rampant caries (10% of dentate patients) and difficulties with dentures (25% of denture wearers) were noted. In addition to pretreatment assessment, continuing oral and dental management is needed for patients with NPC.

Entities:  

Mesh:

Year:  1999        PMID: 10211308     DOI: 10.1016/s1368-8375(98)00072-4

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

Review 1.  Osteoradionecrosis of the jaws--a current overview--Part 2: dental management and therapeutic options for treatment.

Authors:  Bruno Ramos Chrcanovic; Peter Reher; Alexandre Andrade Sousa; Malcolm Harris
Journal:  Oral Maxillofac Surg       Date:  2010-06

Review 2.  Effective health care: management of head and neck cancers.

Authors:  R Collins; A Flynn; A Melville; R Richardson; A Eastwood
Journal:  Qual Saf Health Care       Date:  2005-04

3.  Oral health status of 207 head and neck cancer patients before, during and after radiotherapy.

Authors:  Bruno C Jham; Patricia M Reis; Erika L Miranda; Renata C Lopes; Andre L Carvalho; Mark A Scheper; Addah R Freire
Journal:  Clin Oral Investig       Date:  2007-09-18       Impact factor: 3.573

4.  Multidisciplinary treatment approach in a patient with history of nasopharyngeal carcinoma.

Authors:  Atacan Yavuz; Omer Birkan Ağralı; Zeynep Lale Calışkan; Dilek Türkaydın; Atilla Sertgöz; Bahar Kuru; Başak Doğan
Journal:  Case Rep Dent       Date:  2014-01-09

5.  Saliva substitute mouthwash in nasopharyngeal cancer survivors with xerostomia: a randomized controlled trial.

Authors:  Dayaabaran Marimuthu; Kong Min Han; Mohd Shawal Firdaus Mohamad; Mawaddah Azman
Journal:  Clin Oral Investig       Date:  2020-11-11       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.